Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 3279

1.
2.

Cryptogenic Stroke: Clinical Consideration of a Heterogeneous Ischemic Subtype.

Scullen TA, Monlezun DJ, Siegler JE, George AJ, Schwickrath M, El Khoury R, Cho MC, Martin-Schild S.

J Stroke Cerebrovasc Dis. 2015 Mar 23. pii: S1052-3057(14)00637-5. doi: 10.1016/j.jstrokecerebrovasdis.2014.12.024. [Epub ahead of print]

PMID:
25813058
3.

Antithrombotic treatment at onset of stroke with atrial fibrillation, functional outcome, and fatality: a systematic review and meta-analysis.

Hannon N, Arsava EM, Audebert HJ, Ay H, Crowe M, Ní Chróinín D, Furie K, McGorrian C, Molshatzki N, Murphy S, Noone I, O'Donnell M, Schenkel J, Tan KM, Tanne D, Kelly PJ.

Int J Stroke. 2015 Mar 22. doi: 10.1111/ijs.12473. [Epub ahead of print]

PMID:
25808552
4.

The influence of previous infections and antichlamydia pneumoniae seropositivity on functional outcome in ischemic stroke patients: results from the IN2 study.

Consoli D, Vidale S, Aguglia U, Bassi P, Cavallini A, Consoli A, Galati F, Guidetti D, Micieli G, Neri G, Rasura M, Sterzi R, Toni D, Inzitari D.

J Neurol. 2015 Mar 26. [Epub ahead of print]

PMID:
25808504
5.

Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation.

Zoppellaro G, Granziera S, Padayattil Jose S, Denas G, Bracco A, Iliceto S, Pengo V.

Expert Opin Drug Saf. 2015 Mar 24:1-13. [Epub ahead of print]

PMID:
25803739
6.

Characteristics of Sleep-Disordered Breathing in Etiologic Subtypes of Minor-to-Moderate Acute Ischemic Stroke.

Šiarnik P, Kollár B, Čarnická Z, Šutovský S, Klobučníková K, Turčáni P.

J Stroke Cerebrovasc Dis. 2015 Mar 19. pii: S1052-3057(15)00050-6. doi: 10.1016/j.jstrokecerebrovasdis.2015.01.023. [Epub ahead of print]

PMID:
25802111
7.

Decompensated heart failure is a strong, independent predictor of functional outcome after ischemic stroke.

Burkot J, Kopec G, Pera J, Slowik A, Dziedzic T.

J Card Fail. 2015 Mar 20. pii: S1071-9164(15)00078-0. doi: 10.1016/j.cardfail.2015.03.008. [Epub ahead of print]

PMID:
25800549
8.

Digoxin use and risk of mortality in hypertensive patients with atrial fibrillation.

Okin PM, Hille DA, Wachtell K, Kjeldsen SE, Boman K, Dahlöf B, Devereux RB.

J Hypertens. 2015 Mar 19. [Epub ahead of print]

PMID:
25799208
9.

Novel oral anticoagulants in atrial fibrillation: which novel oral anticoagulant for which patient?

Prisco D, Cenci C, Silvestri E, Ciucciarelli L, Di Minno G.

J Cardiovasc Med (Hagerstown). 2015 Mar 19. [Epub ahead of print]

PMID:
25798903
10.

Pharmacodynamic profile and drug interactions with non-vitamin K antagonist oral anticoagulants: implications for patients with atrial fibrillation.

Xiong Q, Lau YC, Lip GY.

Expert Opin Drug Metab Toxicol. 2015 Mar 22:1-12. [Epub ahead of print]

PMID:
25797167
11.

Metabolic determinants of white matter hyperintensity burden in patients with ischemic stroke.

Cloonan L, Fitzpatrick KM, Kanakis AS, Furie KL, Rosand J, Rost NS.

Atherosclerosis. 2015 Mar 2;240(1):149-153. doi: 10.1016/j.atherosclerosis.2015.02.052. [Epub ahead of print]

PMID:
25795555
12.

Lesion location, stability, and pretreatment management: factors affecting outcomes of endovascular treatment for vertebrobasilar atherosclerosis.

Alexander MD, Rebhun JM, Hetts SW, Kim AS, Nelson J, Kim H, Amans MR, Settecase F, Dowd CF, Halbach VV, Higashida RT, Cooke DL.

J Neurointerv Surg. 2015 Mar 20. pii: neurintsurg-2014-011633. doi: 10.1136/neurintsurg-2014-011633. [Epub ahead of print]

PMID:
25795438
13.

Ischemic stroke: the impact of renal dysfunction on 1-year mortality.

Fabjan TH, Hojs R.

Wien Klin Wochenschr. 2015 Mar 19. [Epub ahead of print]

PMID:
25787210
14.

Five years after mortality of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan.

Sakai K, Kimura K, Ighuchi Y, Yoshioka A, Moriyasu F.

Rinsho Shinkeigaku. 2015;55(3):178-81. doi: 10.5692/clinicalneurol.55.178.

PMID:
25786756
15.

An epidemiological study to evaluate the use of vitamin K antagonists and new oral anticoagulants among non-valvular atrial fibrillation patients in Turkey- AFTER-2 study design.

Ertaş F, Kaya H, Yıldız A, Davutoğlu V, Kiriş A, Dinç L, Kafes H, Avcı A, Calapkorur B, Ertaş G, Gül M, Kahraman Ay N, Bulur S, Durukan M, Eren M, İlhan İ, Küçük M, Özpelit E, Şimşek H, Uçar FM, Yıldız A, Şahin DY, Ayhan E, Çağlayan CE, Güngör H, Özyurtlu F, Şen N, Vatan B, Vatansever F, Kobat MA, Temiz A, Taylan G, Dönmez İ, Erkuş ME, Söylemez S, Zengin H, Gündüz M, Tuncez A, Karavelioğlu Y, Gökdeniz T, Koza Y, Aktop Z, Katlandur H, Karaca Özer P, Yüksel M, Acet H, Çil H, Alan S, Toprak N.

Turk Kardiyol Dern Ars. 2015 Mar;43(2):169-77. doi: 10.5543/tkda.2015.35984.

16.

Anticoagulation for stroke prevention in new atrial fibrillation after coronary artery bypass graft surgery.

Schulman S, Cybulsky I, Delaney J.

Thromb Res. 2015 Feb 25. pii: S0049-3848(15)00087-0. doi: 10.1016/j.thromres.2015.02.015. [Epub ahead of print]

PMID:
25776468
17.

Percutaneous left atrial appendage closure-An alternative strategy for anticoagulation in atrial fibrillation and hereditary hemorrhagic telangiectasia?

Vorselaars VM, Velthuis S, Swaans MJ, Mager JJ, Snijder RJ, Rensing BJ, Boersma LV, Post MC.

Cardiovasc Diagn Ther. 2015 Feb;5(1):49-53. doi: 10.3978/j.issn.2223-3652.2015.01.02.

18.

Critical appraisal of network meta-analyses evaluating the efficacy and safety of new oral anticoagulants in atrial fibrillation stroke prevention trials.

Cope S, Clemens A, Hammès F, Noack H, Jansen JP.

Value Health. 2015 Mar;18(2):234-49. doi: 10.1016/j.jval.2014.10.012. Epub 2015 Jan 28.

PMID:
25773559
19.

Oral Anticoagulation, Aspirin, or No Therapy in Patients With Nonvalvular AF With 0 or 1 Stroke Risk Factor Based on the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score.

Lip GY, Skjøth F, Rasmussen LH, Larsen TB.

J Am Coll Cardiol. 2015 Mar 5. pii: S0735-1097(15)00433-7. doi: 10.1016/j.jacc.2015.01.044. [Epub ahead of print]

PMID:
25770314
20.

Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study.

Xiang W, Zhang J, Liu M, Liu F, Feng X, Wang Y.

Clin Interv Aging. 2015 Mar 2;10:515-9. doi: 10.2147/CIA.S67974. eCollection 2015.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk